Anna Lee Whisenant

This Week in Regulation

TransCanada’s Keystone XL pipeline allowed to run through Nebraska, FCC unveils order to roll back its net-neutrality rules, and more…

This Week in Regulation

FDA approves a pill that tracks when patients take their medication, CFPB director will resign, and more…

This Week in Regulation

Senate Democrats introduce bill that would ban assault weapons, House passes bill that would get rid of employer liability for subcontractors, and more…

This Week in Regulation

Court partially blocks Trump Administration’s transgender military ban, D.C. Circuit stops a fuel efficiency and emissions rule for truck trailers, and more…

This Week in Regulation

Senate votes against banning mandatory arbitration in financial contracts, House passes a bill to curb “sue and settle” practices, and more…

This Week in Regulation

Courts strike down latest version of travel ban, EPA ends “sue and settle” practices, and more…

FDA’s Authority to Regulate Off-Label Promotion

Expert argues that federal law gives regulator authority to restrict unauthorized drug uses.

This Week in Regulation

EPA announces repeal of the Clean Power Plan, President Trump signs an EO to provide “Obamacare relief,” and more…

This Week in Regulation

New CFPB rule protects customers with short-term loans, EPA reportedly fails to follow a deadline on ozone standards, and more…

This Week in Regulation

Trump Administration temporarily waives Jones Act, London does not renew Uber’s operating license, and more…

This Week in Regulation

Court upholds Seattle “use of force” rule, Sierra Club sues EPA for withholding information, and more…

This Week in Regulation

The Supreme Court says the travel ban can prevent certain refugees from entering the U.S., Senator Bernie Sanders introduces a health care bill, and more…